LB1911
Pancreatic Cancer, Colorectal Cancer
Preclinical / Phase 1 (planned)Active
Key Facts
Indication
Pancreatic Cancer, Colorectal Cancer
Phase
Preclinical / Phase 1 (planned)
Status
Active
Company
About Genscript Biotech
Founded in 2002, GenScript Biotech has evolved from a gene synthesis pioneer into a $24+ billion market cap global platform, serving over 200,000 clients worldwide. Its mission is to make biology easier and accelerate the transition from discovery to therapy. The company's strategy leverages its dominant Life Science Services segment as a powerful funnel to drive growth in its high-value Biologics CDMO and Cell Therapy businesses, creating a unique, synergistic ecosystem.
View full company profile